• CNO Financial Group’s Q2 2026 earnings call drew CEO Gary Bhojwani, CFO Paul McDonough, CIO Eric Johnson, IR head Adam Auvil, analysts from KBW, Jefferies, Dowling, Raymond James.
• Operating EPS $1.26, up 45%; full-year operating EPS guidance lifted to $4.60-$4.80, an 8% midpoint increase.
• Capital return totaled $77 million, including $60 million of buybacks; book value per diluted share excluding AOCI $39.92, up 5%.
• Medicare supplement margin benefited from a $4 million reserve release tied to favorable claims development; management did not expect a repeat.
• Management flagged potential second-half free cash flow support from moving Bermuda subsidiaries toward target capital levels, subject to regulatory approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CNO Financial Group Inc. published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.